Samrat Pharmachem Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 81.41 | 82.98 | 62.09 |
| Operating Expense | 78.24 | 81.33 | 61.56 |
| Net Profit | 2.07 | 1.40 | 0.34 |
| Net Profit Margin | 2.54 | 1.69 | 0.55 |
| Earning Per Share | 6.68 | 4.52 | 1.11 |
| EBIDTA | 3.02 | 1.59 | 0.84 |
| Effective Tax Rate | 18.93 | -4.85 | 20.75 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 81.41 |
| Operating Expense | 78.24 |
| Net Profit | 2.07 |
| Net Profit Margin | 2.54 |
| Earning Per Share | 6.68 |
| EBIDTA | 3.02 |
| Effective Tax Rate | 18.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 281.58 | 310.65 | 221.75 |
| Operating Expenses Annual | 279.11 | 286.72 | 197.51 |
| Operating Profit Annual | 3.85 | 24.41 | 24.87 |
| Interest Annual | 0.69 | 1.23 | 0.67 |
| Depreciation | 0.65 | 0.64 | 0.59 |
| Net Profit Annual | 2.16 | 16.63 | 17.18 |
| Tax Annual | 0.36 | 5.90 | 6.42 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 281.58 |
| Operating Expenses Annual | 279.11 |
| Operating Profit Annual | 3.85 |
| Interest Annual | 0.69 |
| Depreciation | 0.65 |
| Net Profit Annual | 2.16 |
| Tax Annual | 0.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 11.86 | 14.71 | 0.24 |
| Cash Flow from Operations | 9.41 | -9.44 | 17.47 |
| Cash Flow from Investing | -0.41 | -3 | -1.06 |
| Cash Flow from Financing | -11.20 | 9.60 | -1.95 |
| Cash Flow at the End | 9.67 | 11.86 | 14.71 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 11.86 |
| Cash Flow from Operations | 9.41 |
| Cash Flow from Investing | -0.41 |
| Cash Flow from Financing | -11.20 |
| Cash Flow at the End | 9.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 1.37 | 7.85 | 11.22 |
| PBIT Margin (%) | 1.14 | 7.65 | 10.95 |
| PBT Margin (%) | -0.51 | 1.43 | -5.38 |
| Net PROFIT Margin (%) | 0.77 | 5.35 | 7.75 |
| Return On Networth / Equity (%) | 3.37 | 30.25 | 44.94 |
| Return On Networth /Employed (%) | 4.14 | 34.91 | 52.32 |
| Return On Assets (%) | 2.78 | 24.41 | 37.03 |
| Total Debt / Equity (X) | 0.21 | 0.24 | 0.21 |
| Asset Turnover Ratio (%) | 3.63 | 4.56 | 4.78 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 1.37 |
| PBIT Margin (%) | 1.14 |
| PBT Margin (%) | -0.51 |
| Net PROFIT Margin (%) | 0.77 |
| Return On Networth / Equity (%) | 3.37 |
| Return On Networth /Employed (%) | 4.14 |
| Return On Assets (%) | 2.78 |
| Total Debt / Equity (X) | 0.21 |
| Asset Turnover Ratio (%) | 3.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 10.72 | 10.70 | 9.99 |
| Total Current Assets Annual | 102.57 | 99.05 | 71.26 |
| Non Current Assets Annual | 19.17 | 17.54 | 13.35 |
| Total Shareholders Funds Annual | 65.00 | 63.14 | 46.82 |
| Total Assets Annual | 121.74 | 116.59 | 84.61 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 10.72 |
| Total Current Assets Annual | 102.57 |
| Non Current Assets Annual | 19.17 |
| Total Shareholders Funds Annual | 65.00 |
| Total Assets Annual | 121.74 |
No Data Availabe
